Solas BioVentures is an early-stage venture capital firm based in Chattanooga, Tennessee, specializing in investments in the life sciences sector, including biopharmaceuticals, medical devices, and digital health technologies.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Solas BioVentures, founded in 2015 and located in Chattanooga, Tennessee, is dedicated to early-stage investments in the life sciences sector. The firm focuses on biopharmaceuticals, medical devices, and digital health, employing a founder-centric approach to foster innovation and improve patient outcomes. With a target fund size of $100 million, Solas BioVentures typically invests between $500,000 and $5 million in seed, Series A, and Series B funding stages. The team comprises professionals with extensive backgrounds in medicine, biotechnology, and finance, committed to enabling breakthrough innovations in healthcare.
Solas BioVentures invests exclusively in the life science sector, targeting early-stage opportunities in biopharmaceuticals, medical devices, and digital health. The firm aims to enable breakthrough innovations that can significantly impact healthcare.
Solas BioVentures adds value through its founder-centric approach, leveraging the team's extensive experience in medical, biotech, and operational fields to guide portfolio companies towards successful commercialization.
Solas BioVentures invests exclusively in the life sciences sector, focusing on early-stage opportunities in biopharmaceuticals, medical devices, and digital health. The firm looks for companies with a clear path to commercialization and a strong founding team.
Startups can pitch to Solas BioVentures through their website at solasbio.com. It is recommended to include a detailed business plan and financial projections in the pitch deck.
The firm emphasizes a founder-centric approach, providing tailored support and leveraging deep expertise in medical, biotech, operational, and financial domains to guide portfolio companies towards successful commercialization.
Solas BioVentures operates on a global scale, targeting early-stage life sciences companies worldwide.
The firm has a fund size of $100 million, with typical check sizes ranging from $250,000 to $5 million.
Solas BioVentures actively engages with its portfolio companies, providing operational support, strategic guidance, and access to their extensive network to help drive growth and innovation.
Organizations that do similar work to Solas BioVentures.
InvestorDeerfield Management is a New York City-based investment management firm specializing in healthcare investments, managing over $15 billion in assets across more than 200 companies. The firm focuses on both public and private investments in sectors such as biotechnology, medical devices, and digital health.
InvestorHuman Capital is a multi-stage venture capital firm that partners with exceptional founders to build companies addressing critical industry challenges. They focus on assembling high-caliber teams and deploying capital to support these ventures.
InvestorEmpowering innovation through strategic investments.
InvestorEmpowering high-growth potential companies in Asia-Pacific.
Superscout Pro
Is this page right?Reviewed · How the research works